Patent · US Active

Method of treating heart failure with modified relaxin polypeptides

US9962450B2 · kind B2 · utility

10Cited by
190References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 17, 2016
Grant dateMay 8, 2018
Priority date—
Expiry dateNov 11, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified relaxin polypeptides and their uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.